187 related articles for article (PubMed ID: 17547534)
1. Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength.
Ammann P; Badoud I; Barraud S; Dayer R; Rizzoli R
J Bone Miner Res; 2007 Sep; 22(9):1419-25. PubMed ID: 17547534
[TBL] [Abstract][Full Text] [Related]
2. Increased bone strength is associated with improved bone microarchitecture in intact female rats treated with strontium ranelate: a finite element analysis study.
Boyd SK; Szabo E; Ammann P
Bone; 2011 May; 48(5):1109-16. PubMed ID: 21276882
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate: a physiological approach for an improved bone quality.
Ammann P
Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
[TBL] [Abstract][Full Text] [Related]
5. Strontium ranelate improves implant osseointegration.
Maïmoun L; Brennan TC; Badoud I; Dubois-Ferriere V; Rizzoli R; Ammann P
Bone; 2010 May; 46(5):1436-41. PubMed ID: 20116464
[TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
Habermann B; Kafchitsas K; Olender G; Augat P; Kurth A
Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.
Bain SD; Jerome C; Shen V; Dupin-Roger I; Ammann P
Osteoporos Int; 2009 Aug; 20(8):1417-28. PubMed ID: 19096745
[TBL] [Abstract][Full Text] [Related]
8. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
Geoffroy V; Chappard D; Marty C; Libouban H; Ostertag A; Lalande A; de Vernejoul MC
Osteoporos Int; 2011 Jan; 22(1):289-97. PubMed ID: 20204596
[TBL] [Abstract][Full Text] [Related]
10. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
[TBL] [Abstract][Full Text] [Related]
11. [Preclinical evaluation of strontium ranelate in bone quality].
Ammann P
Rev Med Suisse Romande; 2004 Feb; 124(2):109-10. PubMed ID: 15095626
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
13. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
15. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
[TBL] [Abstract][Full Text] [Related]
16. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
[TBL] [Abstract][Full Text] [Related]
17. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
18. Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment.
Blake GM; Fogelman I
J Bone Miner Res; 2006 Sep; 21(9):1417-24. PubMed ID: 16939400
[TBL] [Abstract][Full Text] [Related]
19. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
20. Selective modification of bone quality by PTH, pamidronate, or raloxifene.
Brennan TC; Rizzoli R; Ammann P
J Bone Miner Res; 2009 May; 24(5):800-8. PubMed ID: 19063681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
